During the past decade, Morozovsky Children's City Clinical Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Morozovsky Children's City Clinical Hospital" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Anna Vlasova" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation" with 1 trials sponsored and "Materia Medica Holding" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Morozovsky Children's City Clinical Hospital" #1 collaborator was "Morozov Children's Municipal Clinical Hospital of the Moscow City Health Department State-Financed" with 1 trials as a collaborator, "Moscow Healthcare Department" with 1 trials as a collaborator and "Russian Medical Academy of Continuous Professional Education" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Morozovsky Children's City Clinical Hospital" are "Juvenile Idiopathic Arthritis" (2 trials), "Acute Respiratory Viral Infection" (1 trials), "Covid19" (1 trials), "Drug Therapy" (1 trials) and "Solid Tumors Harboring NTRK Fusion" (1 trials). Many other conditions were trialed in "Morozovsky Children's City Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Morozovsky Children's City Clinical Hospital" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Baricitinib" (3 trials), "Gam-COVID-vac M" (1 trials), "Insulin Degludec" (1 trials) and "Insulin Glargine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Morozovsky Children's City Clinical Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Morozovsky Children's City Clinical Hospital". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Morozovsky Children's City Clinical Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Morozovsky Children's City Clinical Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".